BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chen HF, Wu LX, Li XF, Zhu YC, Pan WW, Wang WX, Xu CW, Huang JH, Wu MH, Du KQ. PD-L1 expression level in different thymoma stages and thymic carcinoma: a meta-analysis. Tumori 2020;106:306-11. [PMID: 32366210 DOI: 10.1177/0300891620915788] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Wu Z, Wei F, Zou Y. Effects of programmed death ligand 1 on the prognosis of neuroblastoma: A protocol for systematic review and meta analysis. Medicine (Baltimore) 2021;100:e24920. [PMID: 33655954 DOI: 10.1097/MD.0000000000024920] [Reference Citation Analysis]
2 Liang N, Liu L, Huang C, Liu H, Guo C, Li J, Wang W, Li N, Lin R, Wang T, Ding L, Mao L, Li S. Transcriptomic and Mutational Analysis Discovering Distinct Molecular Characteristics Among Chinese Thymic Epithelial Tumor Patients. Front Oncol 2021;11:647512. [PMID: 34568003 DOI: 10.3389/fonc.2021.647512] [Reference Citation Analysis]
3 Song X, Fan J, Zhu L, Wang Z, He Y, Zhou C. The efficacy and safety of immunotherapy in thymic epithelial tumors: more effective, more risky: a systematic review. J Thorac Dis 2021;13:5093-103. [PMID: 34527346 DOI: 10.21037/jtd-21-290] [Reference Citation Analysis]